Material Transfer Agreements in the UK: Key Terms and Safe Use

If your business needs to send or receive physical samples, prototypes, reagents, datasets on hard drives, cell lines or even confidential prototypes for testing, you’ll want a Material Transfer Agreement (MTA) in place before anything leaves your site.

An MTA sets the ground rules. It defines what the recipient can do with the material, who owns any new intellectual property (IP), who is responsible if something goes wrong, and how the material is stored, returned or destroyed. Getting this right from day one protects your assets, keeps you compliant and prevents costly disputes later.

In this guide, we’ll explain what an MTA is, when your small business might need one, the essential clauses to include under UK law, how MTAs fit with your other contracts, and a practical process to put one in place with confidence.

What Is A Material Transfer Agreement?

A Material Transfer Agreement is a contract between a provider and a recipient that governs the transfer and use of tangible materials. “Materials” can cover almost anything physical or embodied in a medium, for example:

• Biological materials such as cell lines, plasmids, antibodies, microbial strains or clinical samples.
• Chemical compounds, reagents and reference standards.
• Prototypes, components, devices or 3D printed parts for testing and evaluation.
• Datasets on a physical medium (e.g. a drive), firmware images or test code supplied on a device.

Unlike a simple sale or loan, an MTA sets strict limits around what the recipient can do with the materials (for example, internal testing only; non-commercial research only), what happens to derivatives, and who owns any results or inventions created with the materials.

In short, an MTA helps you share materials without accidentally giving away your IP, breaching safety rules or taking on unnecessary liability.

When Would A Small Business Need An MTA?

Many UK SMEs assume MTAs are just for universities and big pharma. In reality, they’re useful across a wide range of sectors. You should consider an MTA when:

• You send a prototype to a manufacturer, lab or test house for evaluation, certification or failure analysis.
• You loan a device or component to a distributor or potential partner for demos or pilot trials.
• You receive reagents, standards or biological materials for R&D work from a supplier or collaborator.
• You ship product samples to a potential buyer for lab testing or comparative benchmarking.
• You provide a physical dataset on a drive for model training or algorithm validation under strict use limits.
• You need to transfer materials to an overseas group company or subcontractor for development work.

Any time the material has commercial value, carries safety or compliance risks, or could lead to new results or inventions, an MTA is a smart move. It lets you control use, protect confidentiality, allocate responsibilities and make sure the material comes back (or is destroyed) when you say so.

Key Clauses To Include In A UK MTA

Every MTA should be tailored to the material and the relationship. However, most well-drafted MTAs will cover the following areas.

Scope Of Transfer And Permitted Use

• Describe the material clearly (including derivatives, progeny, modifications or components if relevant).
• State the permitted use (e.g. non-commercial research, internal evaluation, certification testing) and expressly prohibit any other use without written consent.
• Restrict onward transfer, pledging or posting online without permission.

Ownership, IP And Results

• Confirm the provider retains ownership of the material at all times.
• Deal with IP in results and derivatives. Typical options include:
  • Provider owns all new IP arising from use of the material, with a limited licence to the recipient to use results internally; or
  • Recipient owns new IP in results they create, but the provider gets a non-exclusive licence; or
  • Joint ownership for specific collaborative projects.
• Address background IP on both sides and ensure no implied licence beyond what’s written.

Confidentiality And Data

• Include confidentiality obligations covering the material, results and any accompanying information for an agreed period.
• If personal data will be included with the material (for example, human biological samples with associated metadata), address UK GDPR and the Data Protection Act 2018 responsibilities, minimisation, lawful basis and data security.

Compliance And Safety

• Require the recipient to comply with applicable health and safety rules, standard operating procedures and industry standards relevant to the material.
• For hazardous or biological materials, reference applicable UK regulations (for example, the Control of Substances Hazardous to Health Regulations and, where relevant, local biosafety requirements) and require competent handling, storage and disposal.
• Make clear who is responsible for import/export, customs declarations, and any permits or notifications.

Warranties, Disclaimers And Liability

• Most providers supply materials “as is” without warranties of fitness or merchantability.
• Define the liability position clearly. Many MTAs cap liability and exclude indirect losses, while carving out liability that can’t be excluded under UK law (e.g. for death or personal injury caused by negligence, or fraud).
• Consider indemnities for misuse, breach of law or unsafe handling by the recipient.

Publication And Publicity

• For research contexts, set rules for publication. You might require prior review to remove confidential information or delay publication to allow for patent filings.
• Prohibit using the provider’s name, trade marks or logos in advertising without written permission.

Fees, Cost Recovery And Logistics

• State whether the material is free of charge, provided at cost, or subject to a fee.
• Allocate shipping, insurance and customs costs, and define Incoterms where relevant.
• Include requirements for storage conditions, handling and record-keeping.

Term, Return And Destruction

• Set a clear term for the permitted use.
• Require return or certified destruction at the end of the project or on request, including deletion of any data stored on devices where appropriate.
• Allow audits or confirmations to evidence destruction when the risk profile justifies it.

Governing Law, Jurisdiction And Dispute Resolution

• Choose governing law and courts (commonly the laws of England and Wales and the English courts).
• For cross-border transfers, consider escalation procedures or mediation before litigation.

The exact balance will depend on bargaining power and the project’s goals. As a provider, you’ll want tight use restrictions, strong IP protection and limited liability. As a recipient, you’ll want enough freedom to run your experiments and use results internally, with a route to commercial licences if the project succeeds.

How MTAs Interact With NDAs, IP Licences And Collaboration Agreements

An MTA rarely sits alone. It often works alongside other documents that protect your business and clarify rights as a project evolves.

• Confidentiality before you share: You might start with an Non-Disclosure Agreement so both sides can discuss the material and proposed work without jumping straight into a full MTA.
• Licensing where ongoing use is needed: If the recipient needs rights to use background IP or commercialise results, pair the MTA with an IP Licence that sets the commercial terms, field-of-use and royalties.
• Assigning ownership: Where the intent is that any new IP created will belong to the provider (or transferred to them), you’ll need a formal IP Assignment to move ownership.
• Structured collaboration: When both parties will contribute staff, know-how and resources, it’s common to put a broader Collaboration Agreement in place that covers governance, milestones, funding and background/foreground IP, with the MTA attached as a schedule for the specific material transfers.
• Personal data in or with the material: If personal data is involved, a Data Sharing Agreement or Data Processing Agreement will be needed alongside the MTA, and your customer-facing Privacy Policy should reflect the processing.

Think of the MTA as the “box” around the physical transfer. Your other agreements handle the wider relationship and, if things go well, create a clean pathway from testing to commercialisation.

Step-By-Step: Putting An MTA In Place (Plus Negotiation Tips)

Here’s a practical process you can follow, whether you’re the provider or the recipient.

1) Map The Material And Risks

• List exactly what’s being transferred, including derivatives, components, embedded firmware or data on devices.
• Identify hazards (chemical, biological, mechanical), storage needs, and regulatory touchpoints.
• Flag any personal data or export control issues early so they can be handled correctly.

2) Decide The Commercial Outcome You Want

• Provider: Is this a limited evaluation, or a precursor to a licence or supply deal? Do you want ownership of new IP, or would a licence meet your goals?
• Recipient: What do you need to do with the material to get to a go/no-go decision? Do you need rights to use the results beyond internal R&D?

Being clear on your end-game helps you negotiate the right IP and use terms now, rather than renegotiating mid-project.

3) Get The Right Document Set

• Start with an MTA template aligned to your business model and sector risks.
• Add a separate licence or assignment if commercialisation or ownership transfer is intended.
• Include data privacy schedules where necessary, plus safety instructions or SOPs as annexes.

4) Negotiate The Big Ticket Items First

Focus on the terms that actually shift risk or value:

• Permitted use and restrictions (internal evaluation vs. broader research; any field-of-use limits).
• Foreground IP ownership and licences to results (who owns what, and on what terms).
• Liability caps and indemnities (make them proportionate to the risk and project value).
• Publication/publicity (especially if academic partners are involved).
• Return/destruction, audit rights and what happens at the end of the project.

Negotiation tip: Separate the “test drive” from the “purchase.” Let the MTA govern evaluation with a clear option to discuss a commercial licence if results are positive. That way, neither side is locked into commercial terms too early.

5) Address Compliance Early

• Make sure safety and handling requirements are unambiguous and achievable for the recipient’s facilities and staff.
• Confirm any permits, customs declarations or notifications are assigned to the party best placed to obtain them.
• If personal data is present, confirm the lawful basis, minimisation, security measures and international transfer safeguards.

6) Finalise, Sign And Track

• Record the materials shipped (batch numbers, serials, quantities) in a schedule to the MTA.
• Ensure both sides countersign before shipment, and keep a copy with your project file.
• Set reminders for the end date and return/destruction obligations, and request certificates of destruction where relevant.

Common Pitfalls To Avoid

• Vague material descriptions: If the definition is unclear, you may not control derivatives or embedded software as intended.
• Forgetting background IP: Without clear wording, the recipient might assume broader rights than you intended.
• Overly broad use rights: “Research” sounds harmless but can be interpreted widely. Specify “internal evaluation only” where that’s the goal.
• Misaligned liability caps: A token cap may not protect you if the material is hazardous or high-value-set a realistic limit and carve-outs.
• Silence on data: If personal data is included, address UK GDPR formally rather than tucking it inside general confidentiality.
• No exit plan: Always include a practical return or destruction process with timelines and evidence.

If this sounds like a lot to juggle, don’t stress-once you’ve set up a robust MTA playbook tailored to your business, future transfers become much simpler.

Key Takeaways

• A Material Transfer Agreement protects your business when you share valuable or sensitive materials by defining permitted use, IP, liability, safety and end-of-project obligations.
• SMEs across hardware, life sciences, chemicals and data-driven sectors use MTAs-any time a tangible sample or device is shared for testing or R&D, you should consider one.
• Essential clauses include a precise description of the material, strict use restrictions, clear foreground IP rules, confidentiality, safety and compliance obligations, balanced liability caps, publication rules and robust return/destruction terms.
• MTAs often sit alongside other documents like a Non-Disclosure Agreement, an IP Licence or IP Assignment, and-where personal data is involved-a Data Sharing Agreement or Data Processing Agreement supported by a clear Privacy Policy.
• Map the risks, decide your commercial outcome, negotiate the big-ticket items first and track returns or destruction-setting up a repeatable process protects you from day one and speeds up future transfers.
• Every transfer and relationship is different, so it’s wise to get tailored advice and have your MTAs and related documents professionally drafted to fit your specific materials and goals.

If you’d like help drafting or negotiating a Material Transfer Agreement-or aligning it with an NDA, IP licence or data-sharing paperwork-you can reach us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.